Distinct COPD phenotypes show differences in severity and mortality, with worse outcomes linked to income, race, rural living, and smoking.

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

A clinical trial shows sulthiame lowers breathing interruptions in sleep apnea and improves oxygen levels, raising hope for a medication alternative to CPAP therapy.

During the winter months, when days are short and cold and nights are long and dark, creating a warm and cozy indoor atmosphere can feel especially important.

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.

A new study found that nasal cells act as a first line of defense against the common cold, working together to block ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Air quality has been poor this week in many parts of Finland, according to a report by the Finnish Meteorological Institute (FMI). The concentration of fine particles in the air is especially ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults ...

A decades‑old epilepsy drug halved night‑time breathing pauses in a major sleep apnoea trial; what could this experimental ...